|
|
|||
| |||||||||||||||||||||||||||||||
For many years the treatment of cancers of the gastrointestinal tract has remained static. The advances in the past decade have occurred for the most part not because of new drugs, new surgical techniques, or new forms of radiotherapy. Instead, response rates have improved because of earlier diagnosis and the selection of subgroups of patients likely to benefit from more intensive therapy that combines the various available methods of treatment. More than ever, a multidisciplinary approach to the management of gastrointestinal cancer has been needed. This is especially so in the case of metastatic or recurrent disease, when standard treatment
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |